American Society of Hematology

The American Society of Hematology (ASH) leads the world in promoting and supporting clinical and scientific hematology research through its many innovative award programs, meetings, publications, and advocacy efforts.

ASH Research Agenda

ASH’s roadmap for the prioritization of research support across the hematology community

ASH Research Registry

A research-focused registry that will harness the power of big data to conquer blood diseases worldwide

Sickle Cell Priorities

The Society's top research and training priorities for sickle cell disease and sickle cell trait for the next five years

Research Recommendations

Recommendations, priorities, and action items for various hematology-related initiatives and areas of research

Programs and Awards

Awards and programs offered by ASH to support clinical and scientific hematology research

Precision Medicine Initiative

An initiative to improve genomic profiling of hematologic diseases and identify strategies to improve the use of molecular data in clinical care, research, and education


Blood is an official journal of the American Society of Hematology and the most cited peer-reviewed publication in the field. It is published weekly every Thursday, except for the last week in December. Additionally, an ASH annual meeting abstracts issue is published annually in November.

Blood Advances

Blood Advances, the first journal to join the Blood family in 70 years, is a peer-reviewed, online only, open access journal. Under the direction of founding editor-in-chief Robert Negrin, MD, the inaugural issue made it's debut in November 2016.

View all Diffusion articles
  • Access to Care & Drug Pricing: 2018

    2018 was full of federal policies and proposals related to access to care and drug pricing. The Administration made more changes to the Affordable Care Act and highlighted that drug pricing is a priority.  


  • CMS Releases National Coverage Determination on Next Generation Sequencing

    CMS released a National Coverage Determination entitled Next Generation Sequencing for Medicare Beneficiaries with Advanced Cancer. ASH submitted comments on the proposal along with over 300 other groups, including physician specialty societies, patient advocacy groups, and industry groups.

  • ASH Applauds the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018

    Senators Tim Scott (R-SC) and Cory Booker (D-NJ) introduced the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018.

  • Update on Tax Reform

    On December 20, the House of Representatives and the Senate voted to approve H.R. 1, tax reform legislation. Select members of each chamber came together to resolve disagreements between the two versions passed by the House and Senate.

View all policy news
back to top